| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dyslexia | 22 | 2025 | 30 | 6.810 |
Why?
|
| Juvenile Delinquency | 16 | 2025 | 25 | 6.460 |
Why?
|
| Reading | 26 | 2024 | 75 | 5.990 |
Why?
|
| Language Development Disorders | 17 | 2022 | 176 | 5.990 |
Why?
|
| Mother-Child Relations | 7 | 2026 | 83 | 4.150 |
Why?
|
| Child Development | 10 | 2024 | 267 | 3.960 |
Why?
|
| Cognition | 22 | 2025 | 819 | 3.940 |
Why?
|
| Language Development | 10 | 2025 | 29 | 3.730 |
Why?
|
| Child, Institutionalized | 7 | 2026 | 8 | 3.550 |
Why?
|
| Mothers | 8 | 2026 | 376 | 2.900 |
Why?
|
| Evoked Potentials | 8 | 2025 | 111 | 2.810 |
Why?
|
| Epigenesis, Genetic | 11 | 2024 | 756 | 2.670 |
Why?
|
| Child, Orphaned | 4 | 2025 | 21 | 2.610 |
Why?
|
| Intelligence | 13 | 2019 | 101 | 2.510 |
Why?
|
| DNA Methylation | 10 | 2021 | 1073 | 2.370 |
Why?
|
| Institutionalization | 5 | 2025 | 13 | 2.320 |
Why?
|
| Child | 98 | 2025 | 26098 | 2.180 |
Why?
|
| Violence | 4 | 2025 | 128 | 2.090 |
Why?
|
| Education, Special | 6 | 2019 | 13 | 2.080 |
Why?
|
| Reaction Time | 6 | 2024 | 152 | 1.990 |
Why?
|
| Adolescent | 77 | 2025 | 20727 | 1.990 |
Why?
|
| Brain | 21 | 2025 | 3174 | 1.960 |
Why?
|
| Vulnerable Populations | 3 | 2025 | 148 | 1.900 |
Why?
|
| Stress, Psychological | 6 | 2026 | 538 | 1.880 |
Why?
|
| Humans | 185 | 2026 | 130441 | 1.860 |
Why?
|
| Attention | 4 | 2025 | 191 | 1.760 |
Why?
|
| Oxytocin | 3 | 2026 | 69 | 1.750 |
Why?
|
| Virtual Reality | 2 | 2025 | 35 | 1.720 |
Why?
|
| Russia | 18 | 2021 | 38 | 1.710 |
Why?
|
| Parenting | 5 | 2026 | 347 | 1.710 |
Why?
|
| Language | 8 | 2024 | 216 | 1.680 |
Why?
|
| HIV Infections | 7 | 2025 | 2030 | 1.620 |
Why?
|
| Students | 4 | 2025 | 250 | 1.600 |
Why?
|
| Male | 104 | 2026 | 64473 | 1.580 |
Why?
|
| Military Personnel | 2 | 2025 | 210 | 1.540 |
Why?
|
| Autistic Disorder | 9 | 2019 | 395 | 1.510 |
Why?
|
| Catechol O-Methyltransferase | 9 | 2020 | 27 | 1.470 |
Why?
|
| Hydrocortisone | 4 | 2025 | 213 | 1.470 |
Why?
|
| Electroencephalography | 9 | 2025 | 849 | 1.470 |
Why?
|
| Academic Success | 2 | 2025 | 22 | 1.450 |
Why?
|
| Learning | 6 | 2025 | 369 | 1.450 |
Why?
|
| Cross-Cultural Comparison | 6 | 2016 | 58 | 1.430 |
Why?
|
| Comprehension | 7 | 2024 | 80 | 1.400 |
Why?
|
| Social Perception | 2 | 2026 | 52 | 1.400 |
Why?
|
| Autism Spectrum Disorder | 3 | 2022 | 450 | 1.390 |
Why?
|
| Genetic Predisposition to Disease | 20 | 2025 | 3406 | 1.390 |
Why?
|
| Models, Psychological | 7 | 2012 | 139 | 1.340 |
Why?
|
| Adolescent Development | 3 | 2016 | 29 | 1.320 |
Why?
|
| Female | 93 | 2026 | 70354 | 1.320 |
Why?
|
| Phonetics | 13 | 2024 | 24 | 1.290 |
Why?
|
| Criminals | 2 | 2023 | 19 | 1.280 |
Why?
|
| Polymorphism, Single Nucleotide | 24 | 2025 | 2826 | 1.280 |
Why?
|
| Aptitude | 4 | 2021 | 11 | 1.270 |
Why?
|
| Rural Population | 4 | 2025 | 272 | 1.260 |
Why?
|
| Prisoners | 4 | 2013 | 38 | 1.230 |
Why?
|
| Maternal Behavior | 3 | 2026 | 65 | 1.210 |
Why?
|
| Anger | 3 | 2025 | 31 | 1.210 |
Why?
|
| Child, Preschool | 32 | 2026 | 14944 | 1.190 |
Why?
|
| Child Language | 5 | 2024 | 18 | 1.170 |
Why?
|
| Language Tests | 9 | 2020 | 23 | 1.160 |
Why?
|
| Genetic Linkage | 7 | 2011 | 461 | 1.160 |
Why?
|
| Child Behavior Disorders | 5 | 2020 | 72 | 1.160 |
Why?
|
| Social Environment | 6 | 2012 | 112 | 1.150 |
Why?
|
| Polymorphism, Genetic | 14 | 2020 | 776 | 1.150 |
Why?
|
| Schools | 3 | 2019 | 236 | 1.110 |
Why?
|
| Emotions | 2 | 2021 | 349 | 1.100 |
Why?
|
| Neuropsychological Tests | 10 | 2025 | 953 | 1.080 |
Why?
|
| Hypothalamo-Hypophyseal System | 5 | 2025 | 57 | 1.020 |
Why?
|
| Speech | 4 | 2024 | 63 | 1.000 |
Why?
|
| Genetic Markers | 8 | 2020 | 590 | 0.980 |
Why?
|
| Memory, Short-Term | 3 | 2025 | 139 | 0.970 |
Why?
|
| Orphanages | 4 | 2025 | 7 | 0.970 |
Why?
|
| Recidivism | 3 | 2023 | 6 | 0.960 |
Why?
|
| Young Adult | 24 | 2025 | 9993 | 0.960 |
Why?
|
| Mental Health | 6 | 2026 | 370 | 0.950 |
Why?
|
| Jews | 1 | 2026 | 33 | 0.950 |
Why?
|
| Adoption | 2 | 2016 | 18 | 0.940 |
Why?
|
| Blood-Borne Pathogens | 2 | 2017 | 6 | 0.940 |
Why?
|
| Child Abuse | 4 | 2025 | 223 | 0.930 |
Why?
|
| Psycholinguistics | 4 | 2020 | 7 | 0.930 |
Why?
|
| Psychological Tests | 4 | 2023 | 86 | 0.930 |
Why?
|
| Genotype | 17 | 2020 | 2589 | 0.910 |
Why?
|
| Saliva | 6 | 2026 | 126 | 0.870 |
Why?
|
| Brain Waves | 1 | 2025 | 42 | 0.860 |
Why?
|
| Task Performance and Analysis | 2 | 2024 | 78 | 0.860 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 3 | 2018 | 13 | 0.860 |
Why?
|
| Family Characteristics | 1 | 2025 | 97 | 0.850 |
Why?
|
| Child Behavior | 4 | 2020 | 232 | 0.840 |
Why?
|
| Mental Disorders | 8 | 2018 | 903 | 0.840 |
Why?
|
| Cerebral Cortex | 5 | 2020 | 448 | 0.830 |
Why?
|
| Zambia | 7 | 2025 | 21 | 0.820 |
Why?
|
| Mouth | 1 | 2024 | 69 | 0.820 |
Why?
|
| Child of Impaired Parents | 2 | 2020 | 20 | 0.810 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 430 | 0.800 |
Why?
|
| Teaching | 5 | 2019 | 198 | 0.800 |
Why?
|
| Pituitary-Adrenal System | 4 | 2024 | 33 | 0.800 |
Why?
|
| Haplotypes | 16 | 2020 | 517 | 0.790 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 80 | 0.780 |
Why?
|
| Interpersonal Relations | 1 | 2025 | 222 | 0.780 |
Why?
|
| Genomics | 4 | 2022 | 1618 | 0.770 |
Why?
|
| Language Disorders | 3 | 2016 | 21 | 0.770 |
Why?
|
| Adult | 33 | 2026 | 31121 | 0.760 |
Why?
|
| Housing | 2 | 2020 | 74 | 0.760 |
Why?
|
| Conduct Disorder | 3 | 2015 | 33 | 0.740 |
Why?
|
| Deafness | 1 | 2022 | 79 | 0.730 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2020 | 89 | 0.730 |
Why?
|
| Academic Performance | 1 | 2022 | 24 | 0.720 |
Why?
|
| Endophenotypes | 2 | 2012 | 14 | 0.720 |
Why?
|
| Writing | 2 | 2016 | 59 | 0.700 |
Why?
|
| Knowledge | 1 | 2021 | 48 | 0.690 |
Why?
|
| Longitudinal Studies | 12 | 2022 | 1485 | 0.690 |
Why?
|
| Chromosomes, Human, Pair 6 | 5 | 2025 | 137 | 0.680 |
Why?
|
| Social Support | 2 | 2020 | 363 | 0.670 |
Why?
|
| Multilingualism | 1 | 2021 | 31 | 0.670 |
Why?
|
| Facial Expression | 1 | 2021 | 22 | 0.670 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2012 | 246 | 0.660 |
Why?
|
| Depression | 4 | 2018 | 1313 | 0.660 |
Why?
|
| Connecticut | 6 | 2023 | 20 | 0.650 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2020 | 14 | 0.650 |
Why?
|
| Problem Solving | 2 | 2020 | 61 | 0.650 |
Why?
|
| Multiplex Polymerase Chain Reaction | 2 | 2017 | 35 | 0.650 |
Why?
|
| Benzoxazines | 1 | 2020 | 22 | 0.640 |
Why?
|
| Psychometrics | 5 | 2019 | 676 | 0.640 |
Why?
|
| Alkynes | 1 | 2020 | 26 | 0.640 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2020 | 31 | 0.640 |
Why?
|
| Child, Gifted | 1 | 2020 | 2 | 0.630 |
Why?
|
| Art Therapy | 1 | 2020 | 2 | 0.630 |
Why?
|
| Cyclopropanes | 1 | 2020 | 67 | 0.630 |
Why?
|
| Child Welfare | 1 | 2020 | 70 | 0.630 |
Why?
|
| Psychosocial Deprivation | 1 | 2019 | 5 | 0.620 |
Why?
|
| Machine Learning | 1 | 2024 | 379 | 0.620 |
Why?
|
| Semantics | 4 | 2023 | 47 | 0.620 |
Why?
|
| Nerve Tissue Proteins | 4 | 2025 | 1082 | 0.620 |
Why?
|
| Adolescent Health | 1 | 2020 | 17 | 0.620 |
Why?
|
| Community Health Services | 1 | 2020 | 86 | 0.610 |
Why?
|
| Phenotype | 15 | 2020 | 4472 | 0.610 |
Why?
|
| Personality Assessment | 4 | 2010 | 112 | 0.610 |
Why?
|
| Pharmacogenetics | 2 | 2020 | 202 | 0.610 |
Why?
|
| Criminal Behavior | 1 | 2019 | 2 | 0.600 |
Why?
|
| Carrier Proteins | 3 | 2020 | 1000 | 0.600 |
Why?
|
| Research | 2 | 2020 | 264 | 0.590 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 489 | 0.590 |
Why?
|
| Achievement | 3 | 2014 | 32 | 0.590 |
Why?
|
| Microbiota | 1 | 2024 | 438 | 0.590 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2019 | 15 | 0.580 |
Why?
|
| Child Health | 1 | 2020 | 68 | 0.580 |
Why?
|
| Frontal Lobe | 3 | 2016 | 110 | 0.570 |
Why?
|
| White Matter | 1 | 2021 | 214 | 0.570 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2018 | 40 | 0.570 |
Why?
|
| Social Adjustment | 2 | 2016 | 77 | 0.570 |
Why?
|
| Creativity | 2 | 2016 | 12 | 0.560 |
Why?
|
| Infant | 12 | 2025 | 13228 | 0.560 |
Why?
|
| Down Syndrome | 1 | 2021 | 232 | 0.560 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 115 | 0.550 |
Why?
|
| Speech Disorders | 2 | 2009 | 46 | 0.550 |
Why?
|
| Gene-Environment Interaction | 3 | 2015 | 127 | 0.540 |
Why?
|
| Models, Genetic | 9 | 2013 | 748 | 0.540 |
Why?
|
| Adolescent Behavior | 2 | 2017 | 167 | 0.530 |
Why?
|
| Protozoan Infections | 2 | 2017 | 15 | 0.530 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 182 | 0.530 |
Why?
|
| Neuropsychology | 1 | 2017 | 25 | 0.530 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 780 | 0.510 |
Why?
|
| Genetic Association Studies | 6 | 2017 | 822 | 0.500 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 347 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2025 | 143 | 0.500 |
Why?
|
| Vocabulary | 5 | 2020 | 20 | 0.500 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 1218 | 0.490 |
Why?
|
| Gene Frequency | 15 | 2018 | 731 | 0.480 |
Why?
|
| Emotional Adjustment | 1 | 2016 | 6 | 0.480 |
Why?
|
| Genome-Wide Association Study | 5 | 2020 | 1824 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 891 | 0.470 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2015 | 82 | 0.470 |
Why?
|
| Awareness | 5 | 2013 | 79 | 0.460 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 4035 | 0.450 |
Why?
|
| Polymerase Chain Reaction | 5 | 2013 | 1456 | 0.450 |
Why?
|
| Family | 3 | 2012 | 585 | 0.450 |
Why?
|
| Child, Abandoned | 1 | 2015 | 2 | 0.440 |
Why?
|
| Brain Mapping | 7 | 2021 | 381 | 0.440 |
Why?
|
| Twins | 2 | 2012 | 70 | 0.440 |
Why?
|
| Virus Diseases | 2 | 2017 | 286 | 0.440 |
Why?
|
| Global Health | 1 | 2020 | 627 | 0.440 |
Why?
|
| Child Care | 1 | 2015 | 13 | 0.440 |
Why?
|
| Foster Home Care | 1 | 2015 | 22 | 0.430 |
Why?
|
| Educational Status | 4 | 2020 | 275 | 0.430 |
Why?
|
| Neuroimaging | 3 | 2024 | 382 | 0.430 |
Why?
|
| Prisons | 1 | 2014 | 15 | 0.420 |
Why?
|
| Bacterial Infections | 2 | 2017 | 327 | 0.420 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2015 | 468 | 0.420 |
Why?
|
| Marijuana Smoking | 1 | 2014 | 30 | 0.420 |
Why?
|
| Developing Countries | 3 | 2020 | 302 | 0.410 |
Why?
|
| Gene Expression Profiling | 6 | 2016 | 1807 | 0.410 |
Why?
|
| Genetic Variation | 8 | 2018 | 1541 | 0.400 |
Why?
|
| Cannabis | 1 | 2014 | 49 | 0.400 |
Why?
|
| Models, Educational | 2 | 2011 | 78 | 0.400 |
Why?
|
| Crime | 4 | 2019 | 26 | 0.400 |
Why?
|
| Genetic Testing | 4 | 2021 | 1107 | 0.400 |
Why?
|
| Consensus | 1 | 2015 | 517 | 0.380 |
Why?
|
| Verbal Behavior | 1 | 2012 | 44 | 0.370 |
Why?
|
| Decision Making | 3 | 2013 | 711 | 0.370 |
Why?
|
| Individuality | 4 | 2014 | 37 | 0.370 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2015 | 628 | 0.370 |
Why?
|
| Psychotherapy | 1 | 2015 | 249 | 0.370 |
Why?
|
| Speech Perception | 5 | 2013 | 53 | 0.370 |
Why?
|
| Saudi Arabia | 2 | 2024 | 39 | 0.360 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2333 | 0.360 |
Why?
|
| Maternal Deprivation | 1 | 2011 | 12 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 966 | 0.350 |
Why?
|
| Aggression | 2 | 2012 | 218 | 0.350 |
Why?
|
| Publishing | 1 | 2012 | 105 | 0.340 |
Why?
|
| Mathematics | 1 | 2011 | 71 | 0.340 |
Why?
|
| Auditory Perception | 3 | 2024 | 39 | 0.340 |
Why?
|
| Gene Expression | 3 | 2012 | 1486 | 0.340 |
Why?
|
| Lymphocytes | 1 | 2012 | 348 | 0.340 |
Why?
|
| Risk Factors | 10 | 2018 | 10949 | 0.340 |
Why?
|
| Linguistics | 3 | 2019 | 18 | 0.340 |
Why?
|
| Character | 1 | 2010 | 3 | 0.340 |
Why?
|
| History, 20th Century | 3 | 2019 | 363 | 0.330 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2011 | 107 | 0.330 |
Why?
|
| United States | 10 | 2026 | 11874 | 0.330 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2014 | 175 | 0.330 |
Why?
|
| Educational Measurement | 1 | 2013 | 318 | 0.330 |
Why?
|
| Stroop Test | 2 | 2020 | 7 | 0.320 |
Why?
|
| Cognition Disorders | 2 | 2016 | 552 | 0.320 |
Why?
|
| Checklist | 1 | 2010 | 98 | 0.310 |
Why?
|
| Monoamine Oxidase | 2 | 2010 | 18 | 0.310 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 344 | 0.310 |
Why?
|
| Genome, Human | 3 | 2012 | 1314 | 0.310 |
Why?
|
| Biomedical Research | 1 | 2015 | 558 | 0.300 |
Why?
|
| Aptitude Tests | 1 | 2008 | 3 | 0.290 |
Why?
|
| Remedial Teaching | 1 | 2008 | 4 | 0.290 |
Why?
|
| Reproducibility of Results | 8 | 2019 | 2896 | 0.290 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 1712 | 0.290 |
Why?
|
| Dopamine | 1 | 2010 | 252 | 0.290 |
Why?
|
| Concept Formation | 1 | 2008 | 27 | 0.280 |
Why?
|
| Body Mass Index | 1 | 2014 | 1677 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 3749 | 0.270 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 32 | 0.270 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3798 | 0.270 |
Why?
|
| Behavior | 1 | 2008 | 70 | 0.270 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 2015 | 30 | 0.260 |
Why?
|
| Mutation | 2 | 2020 | 6098 | 0.260 |
Why?
|
| History, 21st Century | 2 | 2019 | 258 | 0.260 |
Why?
|
| Depressive Disorder | 3 | 2008 | 460 | 0.260 |
Why?
|
| Bacteria | 2 | 2024 | 524 | 0.260 |
Why?
|
| Aging | 4 | 2012 | 1243 | 0.250 |
Why?
|
| Neuronal Plasticity | 2 | 2021 | 295 | 0.250 |
Why?
|
| Alleles | 10 | 2018 | 1675 | 0.240 |
Why?
|
| Cohort Studies | 4 | 2025 | 5034 | 0.240 |
Why?
|
| Linkage Disequilibrium | 10 | 2011 | 316 | 0.240 |
Why?
|
| Principal Component Analysis | 3 | 2019 | 151 | 0.240 |
Why?
|
| Genetics, Population | 4 | 2017 | 177 | 0.240 |
Why?
|
| Terminology as Topic | 2 | 2024 | 223 | 0.230 |
Why?
|
| Animals | 13 | 2025 | 33857 | 0.230 |
Why?
|
| DNA Copy Number Variations | 4 | 2022 | 1021 | 0.230 |
Why?
|
| Sleep Deprivation | 1 | 2025 | 44 | 0.230 |
Why?
|
| Parietal Lobe | 3 | 2021 | 46 | 0.220 |
Why?
|
| Internal-External Control | 1 | 2005 | 73 | 0.220 |
Why?
|
| Culture | 2 | 2004 | 69 | 0.220 |
Why?
|
| Microcephaly | 2 | 2021 | 348 | 0.220 |
Why?
|
| Color Perception | 1 | 2024 | 9 | 0.220 |
Why?
|
| Psychopathology | 1 | 2024 | 31 | 0.220 |
Why?
|
| Microsatellite Repeats | 4 | 2011 | 204 | 0.210 |
Why?
|
| Color | 1 | 2024 | 30 | 0.210 |
Why?
|
| Arabs | 1 | 2024 | 29 | 0.210 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2020 | 218 | 0.210 |
Why?
|
| Literacy | 1 | 2024 | 14 | 0.210 |
Why?
|
| Music | 1 | 2024 | 17 | 0.210 |
Why?
|
| Antisocial Personality Disorder | 2 | 2015 | 65 | 0.210 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 525 | 0.210 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2025 | 251 | 0.210 |
Why?
|
| Algorithms | 1 | 2011 | 1663 | 0.200 |
Why?
|
| Pattern Recognition, Visual | 1 | 2003 | 22 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2021 | 145 | 0.200 |
Why?
|
| Metagenomics | 1 | 2024 | 114 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2021 | 171 | 0.200 |
Why?
|
| Transcriptome | 2 | 2025 | 1115 | 0.200 |
Why?
|
| DNA, Bacterial | 2 | 2016 | 480 | 0.200 |
Why?
|
| Verbal Learning | 3 | 2011 | 67 | 0.200 |
Why?
|
| Health Status | 3 | 2015 | 371 | 0.200 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2022 | 24 | 0.190 |
Why?
|
| Megalencephaly | 2 | 2021 | 59 | 0.190 |
Why?
|
| Mammals | 1 | 2024 | 251 | 0.190 |
Why?
|
| Statistics as Topic | 3 | 2010 | 241 | 0.190 |
Why?
|
| Poverty | 2 | 2018 | 454 | 0.190 |
Why?
|
| Blood Platelets | 1 | 2005 | 315 | 0.190 |
Why?
|
| Mental Recall | 2 | 2015 | 137 | 0.180 |
Why?
|
| Genetics, Medical | 1 | 2003 | 119 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2015 | 247 | 0.170 |
Why?
|
| Psychology | 1 | 2001 | 61 | 0.170 |
Why?
|
| Neurites | 1 | 2021 | 44 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2017 | 759 | 0.170 |
Why?
|
| Abnormalities, Multiple | 2 | 2021 | 964 | 0.170 |
Why?
|
| Specialization | 1 | 2001 | 75 | 0.170 |
Why?
|
| Cell Count | 1 | 2021 | 214 | 0.170 |
Why?
|
| Health Risk Behaviors | 1 | 2020 | 7 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 297 | 0.170 |
Why?
|
| Chromosome Mapping | 7 | 2003 | 1046 | 0.170 |
Why?
|
| Pedigree | 6 | 2021 | 1673 | 0.170 |
Why?
|
| Anxiety | 2 | 2018 | 1006 | 0.160 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 126 | 0.160 |
Why?
|
| Public Policy | 1 | 2020 | 54 | 0.160 |
Why?
|
| Interprofessional Relations | 1 | 2001 | 149 | 0.160 |
Why?
|
| Computational Biology | 1 | 2025 | 862 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 1693 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 4 | 2011 | 1210 | 0.160 |
Why?
|
| Residential Facilities | 1 | 2020 | 3 | 0.160 |
Why?
|
| Art | 1 | 2020 | 3 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 832 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 373 | 0.160 |
Why?
|
| Prevalence | 2 | 2019 | 2683 | 0.150 |
Why?
|
| Socialization | 1 | 2019 | 19 | 0.150 |
Why?
|
| Developed Countries | 1 | 2020 | 44 | 0.150 |
Why?
|
| Family Health | 4 | 2008 | 241 | 0.150 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 173 | 0.150 |
Why?
|
| Psychiatry | 1 | 2003 | 272 | 0.150 |
Why?
|
| Social Behavior | 2 | 2019 | 213 | 0.150 |
Why?
|
| Computer Simulation | 4 | 2008 | 671 | 0.150 |
Why?
|
| Age Factors | 2 | 2016 | 2827 | 0.150 |
Why?
|
| Income | 1 | 2020 | 137 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2011 | 363 | 0.140 |
Why?
|
| Psychological Trauma | 2 | 2015 | 28 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 104 | 0.140 |
Why?
|
| Maternal-Child Nursing | 1 | 2018 | 2 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 5153 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3371 | 0.140 |
Why?
|
| Middle Aged | 8 | 2018 | 28395 | 0.130 |
Why?
|
| House Calls | 1 | 2018 | 35 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 388 | 0.130 |
Why?
|
| Politics | 1 | 1998 | 59 | 0.130 |
Why?
|
| Nucleic Acids | 1 | 2017 | 25 | 0.130 |
Why?
|
| Sex Education | 1 | 2017 | 18 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2018 | 65 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2008 | 779 | 0.130 |
Why?
|
| Neurons | 6 | 2016 | 2027 | 0.130 |
Why?
|
| Lod Score | 2 | 2011 | 126 | 0.130 |
Why?
|
| Sex Factors | 3 | 2015 | 1338 | 0.120 |
Why?
|
| Memory | 2 | 2016 | 353 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 1996 | 98 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 380 | 0.120 |
Why?
|
| Hippocampus | 3 | 2017 | 798 | 0.120 |
Why?
|
| Siblings | 1 | 2017 | 201 | 0.120 |
Why?
|
| Parasitemia | 1 | 2016 | 25 | 0.120 |
Why?
|
| Viruses | 1 | 2017 | 115 | 0.120 |
Why?
|
| Texas | 1 | 2025 | 3643 | 0.120 |
Why?
|
| Nerve Net | 1 | 2019 | 259 | 0.120 |
Why?
|
| Choline Kinase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Nodding Syndrome | 1 | 2015 | 1 | 0.120 |
Why?
|
| Urban Population | 1 | 2018 | 282 | 0.120 |
Why?
|
| Blood | 1 | 2016 | 98 | 0.120 |
Why?
|
| Telencephalon | 1 | 2015 | 11 | 0.120 |
Why?
|
| Neurotoxins | 1 | 2015 | 45 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 96 | 0.110 |
Why?
|
| Viremia | 1 | 2016 | 130 | 0.110 |
Why?
|
| Universities | 1 | 2016 | 127 | 0.110 |
Why?
|
| Temporal Lobe | 2 | 2012 | 110 | 0.110 |
Why?
|
| Malaria | 1 | 2015 | 95 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 173 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1206 | 0.110 |
Why?
|
| Self Report | 1 | 2018 | 553 | 0.110 |
Why?
|
| Maternal-Fetal Relations | 1 | 2014 | 19 | 0.110 |
Why?
|
| Prostatectomy | 1 | 2015 | 303 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2023 | 3676 | 0.110 |
Why?
|
| Health Status Indicators | 1 | 2014 | 111 | 0.100 |
Why?
|
| Taq Polymerase | 1 | 2013 | 7 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2021 | 6424 | 0.100 |
Why?
|
| Disease Progression | 1 | 2020 | 2194 | 0.100 |
Why?
|
| Choline | 1 | 2014 | 48 | 0.100 |
Why?
|
| DNA, Protozoan | 1 | 2013 | 26 | 0.100 |
Why?
|
| Visual Perception | 2 | 2012 | 127 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 255 | 0.100 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1087 | 0.100 |
Why?
|
| Limit of Detection | 1 | 2013 | 74 | 0.100 |
Why?
|
| Body Height | 1 | 2014 | 194 | 0.100 |
Why?
|
| Malnutrition | 1 | 2015 | 156 | 0.100 |
Why?
|
| Selection, Genetic | 3 | 2011 | 151 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 138 | 0.100 |
Why?
|
| Base Sequence | 4 | 2013 | 2734 | 0.100 |
Why?
|
| Mental Processes | 2 | 2010 | 36 | 0.100 |
Why?
|
| Cell Line | 3 | 2014 | 2557 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2015 | 213 | 0.100 |
Why?
|
| USSR | 1 | 2012 | 4 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2014 | 193 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2015 | 242 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 384 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2011 | 742 | 0.100 |
Why?
|
| Sequence Analysis | 1 | 2012 | 50 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 995 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 408 | 0.090 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 80 | 0.090 |
Why?
|
| Autopsy | 1 | 2012 | 113 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2013 | 166 | 0.090 |
Why?
|
| Homozygote | 1 | 2014 | 535 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2015 | 934 | 0.090 |
Why?
|
| DNA, Viral | 1 | 2013 | 452 | 0.090 |
Why?
|
| Chromosome Breakpoints | 1 | 2011 | 82 | 0.090 |
Why?
|
| Neocortex | 1 | 2012 | 75 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 67 | 0.090 |
Why?
|
| Bacteremia | 1 | 2016 | 429 | 0.090 |
Why?
|
| Semaphorins | 1 | 2011 | 39 | 0.090 |
Why?
|
| Cattle | 1 | 2012 | 502 | 0.090 |
Why?
|
| Comorbidity | 2 | 2011 | 1583 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 236 | 0.090 |
Why?
|
| Exome | 1 | 2016 | 1063 | 0.080 |
Why?
|
| Mice | 4 | 2024 | 18229 | 0.080 |
Why?
|
| Stem Cell Research | 1 | 2011 | 5 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2014 | 3355 | 0.080 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 146 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2011 | 31 | 0.080 |
Why?
|
| Neuropsychiatry | 1 | 2011 | 12 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2011 | 102 | 0.080 |
Why?
|
| Occipital Lobe | 1 | 2011 | 31 | 0.080 |
Why?
|
| Mosaicism | 1 | 2012 | 247 | 0.080 |
Why?
|
| Impulsive Behavior | 1 | 2012 | 161 | 0.080 |
Why?
|
| CpG Islands | 1 | 2011 | 334 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 178 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2011 | 86 | 0.080 |
Why?
|
| Body Weight | 1 | 2014 | 984 | 0.080 |
Why?
|
| Bias | 1 | 2010 | 147 | 0.080 |
Why?
|
| Poisson Distribution | 1 | 2010 | 50 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 615 | 0.080 |
Why?
|
| Gambia | 1 | 2009 | 26 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 309 | 0.080 |
Why?
|
| Chromosome Inversion | 1 | 2010 | 70 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 210 | 0.080 |
Why?
|
| Time Factors | 3 | 2016 | 6201 | 0.080 |
Why?
|
| Intelligence Tests | 2 | 2004 | 61 | 0.080 |
Why?
|
| Skin | 1 | 2012 | 536 | 0.080 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 316 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2004 | 422 | 0.070 |
Why?
|
| Phylogeny | 2 | 2010 | 687 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2004 | 645 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1872 | 0.070 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2009 | 16 | 0.070 |
Why?
|
| Netherlands | 1 | 2008 | 50 | 0.070 |
Why?
|
| Forecasting | 2 | 2001 | 350 | 0.070 |
Why?
|
| Organizational Affiliation | 1 | 2008 | 2 | 0.070 |
Why?
|
| Asperger Syndrome | 1 | 2008 | 8 | 0.070 |
Why?
|
| Receptors, Prolactin | 1 | 2008 | 24 | 0.070 |
Why?
|
| Receptors, Oxytocin | 1 | 2008 | 21 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 151 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2011 | 298 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1367 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2008 | 53 | 0.070 |
Why?
|
| Parents | 1 | 2015 | 1116 | 0.070 |
Why?
|
| Prolactin | 1 | 2008 | 142 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 1405 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1585 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2008 | 108 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2008 | 171 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2013 | 1444 | 0.060 |
Why?
|
| Exons | 3 | 2025 | 760 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 395 | 0.060 |
Why?
|
| Counseling | 2 | 1998 | 235 | 0.060 |
Why?
|
| Underachievement | 1 | 2006 | 1 | 0.060 |
Why?
|
| Vitamins | 1 | 2007 | 112 | 0.060 |
Why?
|
| Genome | 1 | 2009 | 453 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 901 | 0.060 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 18 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1799 | 0.060 |
Why?
|
| Helminthiasis | 1 | 2007 | 83 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 675 | 0.060 |
Why?
|
| Forensic Genetics | 1 | 2005 | 15 | 0.060 |
Why?
|
| Schizophrenia | 2 | 2009 | 323 | 0.060 |
Why?
|
| DNA Fingerprinting | 1 | 2005 | 106 | 0.060 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 47 | 0.060 |
Why?
|
| Exploratory Behavior | 1 | 2005 | 52 | 0.060 |
Why?
|
| Logistic Models | 1 | 2010 | 1793 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 1374 | 0.060 |
Why?
|
| Interview, Psychological | 1 | 2005 | 101 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2008 | 1209 | 0.050 |
Why?
|
| Aged | 5 | 2016 | 20888 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2025 | 124 | 0.050 |
Why?
|
| Judgment | 1 | 2024 | 37 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2024 | 91 | 0.050 |
Why?
|
| Genetic Drift | 1 | 2004 | 20 | 0.050 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2004 | 41 | 0.050 |
Why?
|
| Heterozygote | 3 | 2017 | 725 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2025 | 260 | 0.050 |
Why?
|
| Software | 2 | 2000 | 731 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 244 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2015 | 4670 | 0.050 |
Why?
|
| Sample Size | 2 | 2000 | 84 | 0.050 |
Why?
|
| DNA | 2 | 2005 | 1400 | 0.040 |
Why?
|
| Receptors, GABA-B | 1 | 2001 | 11 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2088 | 0.040 |
Why?
|
| Twin Studies as Topic | 1 | 2001 | 13 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1592 | 0.040 |
Why?
|
| Photic Stimulation | 2 | 2012 | 227 | 0.040 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2001 | 14 | 0.040 |
Why?
|
| HIV Seropositivity | 2 | 1998 | 125 | 0.040 |
Why?
|
| Research Design | 1 | 2005 | 712 | 0.040 |
Why?
|
| Seizures | 2 | 2021 | 876 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2021 | 87 | 0.040 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2000 | 15 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2001 | 39 | 0.040 |
Why?
|
| Smoking | 1 | 2005 | 928 | 0.040 |
Why?
|
| Environment | 1 | 2001 | 149 | 0.040 |
Why?
|
| DNA Primers | 3 | 2009 | 600 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 237 | 0.040 |
Why?
|
| Grief | 1 | 1998 | 21 | 0.040 |
Why?
|
| Prognosis | 1 | 2008 | 4861 | 0.040 |
Why?
|
| Attitude to Death | 1 | 1998 | 38 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 443 | 0.030 |
Why?
|
| Pregnancy | 3 | 2018 | 7395 | 0.030 |
Why?
|
| Nurse-Patient Relations | 1 | 2018 | 10 | 0.030 |
Why?
|
| Syndrome | 1 | 2001 | 1158 | 0.030 |
Why?
|
| Personality Disorders | 1 | 2001 | 175 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 654 | 0.030 |
Why?
|
| Women's Health | 1 | 1998 | 133 | 0.030 |
Why?
|
| Minisatellite Repeats | 2 | 2009 | 43 | 0.030 |
Why?
|
| Babesia microti | 1 | 2016 | 2 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2015 | 17514 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 325 | 0.030 |
Why?
|
| Francisella tularensis | 1 | 2016 | 16 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 1998 | 314 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 172 | 0.030 |
Why?
|
| Probability | 1 | 1997 | 305 | 0.030 |
Why?
|
| Culture Media | 1 | 2016 | 169 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1997 | 148 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 410 | 0.030 |
Why?
|
| War Exposure | 1 | 2015 | 7 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 2289 | 0.030 |
Why?
|
| Exposure to Violence | 1 | 2015 | 11 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2016 | 147 | 0.030 |
Why?
|
| Health Policy | 1 | 1998 | 225 | 0.030 |
Why?
|
| Intimate Partner Violence | 1 | 2015 | 30 | 0.030 |
Why?
|
| Pregnancy in Adolescence | 1 | 2015 | 53 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 232 | 0.030 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 74 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 302 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 273 | 0.030 |
Why?
|
| Social Skills | 1 | 2014 | 15 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 585 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2012 | 1920 | 0.030 |
Why?
|
| Speech Discrimination Tests | 1 | 2014 | 1 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 1998 | 551 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3469 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2014 | 72 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2013 | 110 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 559 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1071 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 2 | 2004 | 37 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1000 | 0.020 |
Why?
|
| Clone Cells | 1 | 2012 | 152 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1998 | 915 | 0.020 |
Why?
|
| Organoids | 1 | 2015 | 301 | 0.020 |
Why?
|
| Imagination | 1 | 1992 | 13 | 0.020 |
Why?
|
| Eye Color | 1 | 2011 | 5 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1388 | 0.020 |
Why?
|
| Psychology, Adolescent | 1 | 1992 | 34 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 1992 | 46 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2011 | 28 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1280 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 726 | 0.020 |
Why?
|
| Globus Pallidus | 1 | 2012 | 68 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 1992 | 124 | 0.020 |
Why?
|
| Cellular Reprogramming | 1 | 2012 | 128 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2016 | 991 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 364 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2015 | 702 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 131 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1383 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 229 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 78 | 0.020 |
Why?
|
| Ireland | 1 | 2010 | 33 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2012 | 125 | 0.020 |
Why?
|
| Genomic Structural Variation | 1 | 2011 | 96 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 411 | 0.020 |
Why?
|
| Primates | 1 | 2010 | 81 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 356 | 0.020 |
Why?
|
| Genetics, Behavioral | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cues | 1 | 2009 | 81 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2001 | 132 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2010 | 276 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2009 | 252 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 852 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 1270 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 418 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 269 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2894 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1317 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6788 | 0.010 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2004 | 1 | 0.010 |
Why?
|
| Hominidae | 1 | 2004 | 27 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2551 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 500 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2001 | 65 | 0.010 |
Why?
|
| Population Growth | 1 | 2001 | 5 | 0.010 |
Why?
|
| Introns | 1 | 2001 | 279 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2000 | 115 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 4667 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 139 | 0.010 |
Why?
|
| Indians, North American | 1 | 2000 | 71 | 0.010 |
Why?
|
| Community Mental Health Services | 1 | 1998 | 43 | 0.010 |
Why?
|
| Life Change Events | 1 | 1998 | 59 | 0.010 |
Why?
|
| AIDS Serodiagnosis | 1 | 1998 | 52 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8520 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 564 | 0.010 |
Why?
|
| Self Concept | 1 | 1998 | 157 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1998 | 231 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2001 | 922 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 330 | 0.010 |
Why?
|
| Personality Inventory | 1 | 1995 | 178 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1995 | 221 | 0.010 |
Why?
|